Dr. Vivek Bhalla, MD

Dr. Bhalla practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Bhalla's NPI, 1730118738, was assigned on July 2, 2006. Dr. Bhalla graduated from UC San Diego School of Medicine in 1998. Dr. Bhalla's California license number on file is A70125.

Dr. Bhalla's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Bhalla's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Bhalla to 1 more hospital and 1 medical group, each named with a free account. Dr. Bhalla's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhalla practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Bhalla's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bhalla is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Bhalla's licenses on file in 2 states: California and Oregon.

Dmand AI lists chronic kidney disease and hypercalcemia among the conditions Dr. Bhalla treats.

CMS data shows 315 Medicare services from Dr. Bhalla across 7 procedure codes in 2024, for 166 Medicare patients. Medicare paid $21,084 for them.

CMS counts 166 Medicare patients who saw Dr. Bhalla in 2024. The largest group is 75 to 84, with 56 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 43% are also on Medicaid. Their average risk score is 5.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhalla's median patient age at 59, with 46% women.

In 2024, Dr. Bhalla wrote 407 Medicare Part D claims for 89 patients. 90% of them were for generic drugs. CMS names the drug for 263 of them, across 10 drugs with 11 or more claims each, at $33,356 in total drug cost. In 2023, CMS named 453 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Bhalla for performance year 2024, reported as part of a group. Dr. Bhalla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhalla as offering telehealth.

Dmand AI links 59 papers to Dr. Bhalla, published from 2005 to 2025. 2020 was the busiest year, with 10. The most frequent topics are Hypertension, Blood Pressure and Aldosterone. Dr. Bhalla has published most often in Am J Physiol Renal Physiol. Dr. Bhalla's most frequent co-authors are Vivek Bhalla, MD, Glenn Matthew Chertow, MD and Alan Chun-Yao Pao, MD.

CMS Open Payments shows 117 general payments to Dr. Bhalla from 8 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 74% of the total. Medtronic, Inc. paid the most, $23,448.

Dmand AI lists 16 awards for Dr. Bhalla, most recently Fellow in 2017. Dr. Bhalla serves on Kidney and Cardiovascular Council American Heart Association.

Dr. Bhalla graduated from UC San Diego School of Medicine in 1998. Dr. Bhalla is a member of AHA and ASN.

Dr. Bhalla is in network with 10 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.